Bausch Health Companies Inc. (BHC)
NYSE: BHC · IEX Real-Time Price · USD
7.60
+0.22 (2.98%)
At close: Jul 19, 2024, 4:00 PM
7.61
+0.01 (0.13%)
After-hours: Jul 20, 2024, 12:56 PM EDT
Bausch Health Companies Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for BHC stock have an average target of 11.67, with a low estimate of 8.00 and a high estimate of 16. The average target predicts an increase of 53.55% from the current stock price of 7.60.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BHC stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Hold Initiates $8 | Hold | Initiates | $8 | +5.26% | Jul 10, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $12 → $11 | Hold | Maintains | $12 → $11 | +44.74% | Apr 23, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $12 | Hold | Reiterates | $12 | +57.89% | Apr 12, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $9 → $12 | Hold | Maintains | $9 → $12 | +57.89% | Apr 5, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +18.42% | Feb 23, 2024 |
Financial Forecast
Revenue This Year
9.50B
from 8.76B
Increased by 8.51%
Revenue Next Year
9.83B
from 9.50B
Increased by 3.45%
EPS This Year
3.69
from -1.62
EPS Next Year
4.50
from 3.69
Increased by 22.12%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 9.9B | 10.4B | 10.7B | 10.7B | 10.1B |
| Avg | 9.5B | 9.8B | 10.1B | 10.3B | 9.7B |
| Low | 9.2B | 9.4B | 9.7B | 10.0B | 9.4B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 13.5% | 9.1% | 8.6% | 6.2% | -2.3% |
| Avg | 8.5% | 3.5% | 2.8% | 2.2% | -6.0% |
| Low | 4.8% | -0.6% | -1.5% | -0.9% | -8.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 4.16 | 5.20 | 5.83 |
| Avg | 3.69 | 4.50 | 5.17 |
| Low | 3.10 | 3.74 | 4.61 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 41.0% | 29.5% |
| Avg | - | 22.1% | 14.9% |
| Low | - | 1.6% | 2.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.